Ramiro Ribeiro is Chief Medical Officer of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of EYPT, which is worth approximately $0. The most recent transaction as insider was on Jan 05, 2026, when has been sold 42,544 shares (Common Stock) at a price of $17.1 per share, resulting in proceeds of $727,502. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Ramiro Ribeiro Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2026
SELL
Open market or private sale
$727,502 $17.1 p/Share
42,544 Reduced 100.0%
0 Common Stock
Jan 05 2026
BUY
Exercise of conversion of derivative security
$241,605 $8.26 p/Share
29,250 Added 40.74%
42,544 Common Stock
Jan 03 2026
SELL
Payment of exercise price or tax liability
$111,400 $17.48 p/Share
6,373 Reduced 32.4%
13,294 Common Stock
Jan 03 2026
BUY
Exercise of conversion of derivative security
-
19,667 Added 50.0%
19,667 Common Stock
Nov 11 2025
SELL
Open market or private sale
$31,602 $11.61 p/Share
2,722 Reduced 100.0%
0 Common Stock
RR

Ramiro Ribeiro

Chief Medical Officer
Watertown, MA

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Track Activities on EYPT